Connor, Clark & Lunn Investment Management Ltd. Synlogic, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$22 Billion
Q2 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.91 - $14.63 $769 - $12,376	846 Added 7.79%	11,705 $11,000
Q2 2022 Aug 05, 2022	SELL	$0.89 - $2.47 $15,639 - $43,402	-17,572 Reduced 61.81%	10,859 $12,000
Q1 2022 May 12, 2022	SELL	$1.63 - $2.55 $6,079 - $9,511	-3,730 Reduced 11.6%	28,431 $68,000
Q4 2021 Feb 10, 2022	BUY	$2.27 - $3.0 $73,005 - $96,483	32,161 New	32,161 $78,000
Q3 2020 Nov 12, 2020	SELL	$1.85 - $2.57 $54,001 - $75,018	-29,190 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$1.59 - $2.51 $21,162 - $33,408	-13,310 Reduced 31.32%	29,190 $59,000
Q1 2020 May 13, 2020	BUY	$1.39 - $3.19 $39,198 - $89,958	28,200 Added 197.2%	42,500 $73,000
Q4 2019 Feb 12, 2020	BUY	$1.96 - $2.81 $28,028 - $40,183	14,300 New	14,300 $37,000

Others Institutions Holding SYBX

# of Institutions

Shares Held

25.5K

Call Options Held

Put Options Held

View Full List

About SYNLOGIC, INC.

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

More about SYBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account